These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 36305994)

  • 1. Letter to the Editor.
    Goodman A; Velazquez-Vega J; Olson J
    J Neurooncol; 2022 Nov; 160(2):341-343. PubMed ID: 36305994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of neuropathology in the management of newly diagnosed glioblastoma: a systematic review and evidence-based clinical practice guideline.
    Velázquez Vega JE; Brat DJ; Ryken TC; Olson JJ
    J Neurooncol; 2020 Nov; 150(2):143-164. PubMed ID: 33215342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond the World Health Organization classification of central nervous system tumors 2016: what are the new developments for gliomas from a clinician's perspective?
    Weller M; Reifenberger G
    Curr Opin Neurol; 2020 Dec; 33(6):701-706. PubMed ID: 33177376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced Magnetic Resonance Imaging in Pediatric Glioblastomas.
    Gonçalves FG; Viaene AN; Vossough A
    Front Neurol; 2021; 12():733323. PubMed ID: 34858308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Congress of Neurological Surgeons systematic review and evidence-based guidelines for the treatment of adults with progressive glioblastoma update: introduction and methods.
    Olson JJ
    J Neurooncol; 2022 Jun; 158(2):133-137. PubMed ID: 34694566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glioblastoma: Changing concepts in the WHO CNS5 classification.
    Chen J; Han P; Dahiya S
    Indian J Pathol Microbiol; 2022 May; 65(Supplement):S24-S32. PubMed ID: 35562131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Glioblastoma, IDH-Wildtype].
    Shibahara I; Kumabe T
    No Shinkei Geka; 2023 Sep; 51(5):821-828. PubMed ID: 37743333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reclassification of Glioblastoma Multiforme According to the 2021 World Health Organization Classification of Central Nervous System Tumors: A Single Institution Report and Practical Significance.
    Stoyanov GS; Lyutfi E; Georgieva R; Georgiev R; Dzhenkov DL; Petkova L; Ivanov BD; Kaprelyan A; Ghenev P
    Cureus; 2022 Feb; 14(2):e21822. PubMed ID: 35291535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Management of Progressive Glioblastoma in Adults: Update of the 2014 Guidelines.
    Germano IM; Johnson DR; Patrick HH; Goodman AL; Ziu M; Ormond DR; Olson JJ
    Neurosurgery; 2022 May; 90(5):e112-e115. PubMed ID: 35426875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of the molecular classification of glioblastoma on the interpretation of therapeutic clinical trial results.
    Singer LS; Feldman AZ; Buerki RA; Horbinski CM; Lukas RV; Stupp R
    Chin Clin Oncol; 2021 Aug; 10(4):38. PubMed ID: 34118826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congress of neurological surgeons systematic review and evidence-based clinical practice parameter guidelines for the treatment of adults with newly diagnosed glioblastoma: Introduction and Methods.
    Olson JJ; Ryken TC
    J Neurooncol; 2020 Nov; 150(2):87-93. PubMed ID: 33215339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted next-generation sequencing of adult gliomas for retrospective prognostic evaluation and up-front diagnostics.
    Petersen JK; Boldt HB; Sørensen MD; Blach S; Dahlrot RH; Hansen S; Burton M; Thomassen M; Kruse T; Poulsen FR; Andreasen L; Hager H; Ulhøi BP; Lukacova S; Reifenberger G; Kristensen BW
    Neuropathol Appl Neurobiol; 2021 Feb; 47(1):108-126. PubMed ID: 32696543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Major Changes in 2021 World Health Organization Classification of Central Nervous System Tumors.
    Kurokawa R; Kurokawa M; Baba A; Ota Y; Pinarbasi E; Camelo-Piragua S; Capizzano AA; Liao E; Srinivasan A; Moritani T
    Radiographics; 2022; 42(5):1474-1493. PubMed ID: 35802502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entities.
    Reinhardt A; Stichel D; Schrimpf D; Koelsche C; Wefers AK; Ebrahimi A; Sievers P; Huang K; Casalini MB; Fernández-Klett F; Suwala A; Weller M; Gramatzki D; Felsberg J; Reifenberger G; Becker A; Hans VH; Prinz M; Staszewski O; Acker T; Dohmen H; Hartmann C; Paulus W; Heß K; Brokinkel B; Schittenhelm J; Buslei R; Deckert M; Mawrin C; Hewer E; Pohl U; Jaunmuktane Z; Brandner S; Unterberg A; Hänggi D; Platten M; Pfister SM; Wick W; Herold-Mende C; Korshunov A; Reuss DE; Sahm F; Jones DTW; Capper D; von Deimling A
    Acta Neuropathol Commun; 2019 Oct; 7(1):163. PubMed ID: 31661039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 2016 WHO Classification of Tumours of the Central Nervous System: The Major Points of Revision.
    Komori T
    Neurol Med Chir (Tokyo); 2017 Jul; 57(7):301-311. PubMed ID: 28592714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cIMPACT-NOW updates and their significance to current neuro-oncology practice.
    Gonzalez Castro LN; Wesseling P
    Neurooncol Pract; 2021 Feb; 8(1):4-10. PubMed ID: 33664964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of epidemiological characteristics of supratentorial gliomas in adults brought about by the 2016 world health organization classification of tumors of the central nervous system.
    Jiang H; Cui Y; Wang J; Lin S
    Oncotarget; 2017 Mar; 8(12):20354-20361. PubMed ID: 27888628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. cIMPACT-NOW update 3: recommended diagnostic criteria for "Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV".
    Brat DJ; Aldape K; Colman H; Holland EC; Louis DN; Jenkins RB; Kleinschmidt-DeMasters BK; Perry A; Reifenberger G; Stupp R; von Deimling A; Weller M
    Acta Neuropathol; 2018 Nov; 136(5):805-810. PubMed ID: 30259105
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical significance of the 2016 WHO classification in Japanese patients with gliomas.
    Iuchi T; Sugiyama T; Ohira M; Kageyama H; Yokoi S; Sakaida T; Hasegawa Y; Setoguchi T; Itami M
    Brain Tumor Pathol; 2018 Apr; 35(2):71-80. PubMed ID: 29470683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical neuropathology update: a review of changes introduced by the WHO classification of tumours of the central nervous system, 4th edition.
    Brat DJ; Parisi JE; Kleinschmidt-DeMasters BK; Yachnis AT; Montine TJ; Boyer PJ; Powell SZ; Prayson RA; McLendon RE;
    Arch Pathol Lab Med; 2008 Jun; 132(6):993-1007. PubMed ID: 18517285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.